Molecular Partners AG ADR Financials
MOLN
All currency values in CHF millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | CHF 0 | CHF 0 | CHF 5 | CHF 7 | CHF 190 | CHF 9 |
| Operating Income | -CHF 52 | -CHF 55 | -CHF 61 | -CHF 61 | CHF 117 | -CHF 63 |
| Non-Operating | ||||||
| Net Interest Expense | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 1 | -CHF 1 |
| Income Tax Expense | CHF 0 | CHF 0 | CHF 0 | CHF 0 | CHF 0 | CHF 0 |
| Net Income | ||||||
| Net Income | -CHF 51 | -CHF 62 | -CHF 54 | -CHF 62 | CHF 118 | -CHF 64 |
| Per Share Data | ||||||
| Revenue Per Share | CHF 0.00 | CHF 0.00 | CHF 0.15 | CHF 0.24 | CHF 6.48 | CHF 0.33 |
| EPS (Basic) | -CHF 1.37 | -CHF 1.65 | -CHF 1.59 | -CHF 1.89 | CHF 3.63 | -CHF 2.06 |
| EPS (Diluted) | -CHF 1.37 | -CHF 1.65 | -CHF 1.59 | -CHF 1.89 | CHF 3.54 | -CHF 2.06 |
| Shares Outstanding | 38.3M | 37.3M | 34.0M | 28.8M | 29.3M | 27.9M |
Molecular Partners AG ADR (MOLN) financials: revenue, profit and margins
Molecular Partners AG ADR (MOLN) generated about CHF 0.00 in revenue and -CHF 51 million in net income over the trailing twelve months, growing at roughly -18.9% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Molecular Partners AG ADR's (MOLN) revenue?+
Molecular Partners AG ADR generated about CHF 0.00 in revenue over the trailing twelve months. Revenue has grown at roughly -18.9% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Molecular Partners AG ADR profitable?+
Molecular Partners AG ADR reported about -CHF 51 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
How fast is Molecular Partners AG ADR growing?+
Molecular Partners AG ADR's revenue has compounded at roughly -18.9% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside MOLN's margins and free cash flow. This is analysis from company filings, not investment advice.
Peers
Biotechnology · Pick stocks to compare with MOLN
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MOLN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.